Search

Displaying results 5831 - 5840 of 7479 in total
  1. Drug

    Adarigiline

    go.drugbank.com/drugs/DB21418
    Experimental

    Adarigiline has a monoisotopic molecular weight of 360.08 Da.

  2. Drug

    Oxmetidine

    go.drugbank.com/drugs/DB21430
    Experimental

    Oxmetidine has a monoisotopic molecular weight of 399.14 Da.

  3. Drug

    Tisolagiline

    go.drugbank.com/drugs/DB21655
    Experimental

    Tisolagiline has a monoisotopic molecular weight of 322.13 Da.

  4. Drug

    Mosperafenib

    go.drugbank.com/drugs/DB21673
    Experimental

    Mosperafenib has a monoisotopic molecular weight of 461.1 Da.

  5. Drug

    NS-3728

    go.drugbank.com/drugs/DB05835
    Experimental

    NS3728 is an orally active chloride channel blocker for the treatment of cancer.

  6. Drug

    NKX101

    go.drugbank.com/drugs/DB18131
    Investigational

    NKX101 is an investigational allogeneic chimeric antigen receptor (CAR)-natural killer cell therapy.

    Synonyms: a fourth generation activating chimeric receptor (ACR) natural killer (NK) cell therapy engineered with an NKG2D ACR, OX40 costimulatory domain, CD3zeta signaling moiety, and membrane bound IL-15 (mb-IL15
  7. Drug

    Rotigotine

    go.drugbank.com/drugs/DB05271
    ApprovedInvestigational

    However, all Neupro patches in the United States and some of Europe were recalled in 2008 due to delivery mechanism issues. Rotigotine has been authorized as a treatment for RLS since August 2008.

  8. Drug

    OXI-4503

    go.drugbank.com/drugs/DB05143
    Investigational

    OXI-4503 (combretastatin A1 di-phosphate / CA1P) is a unique and highly potent, dual-mechanism vascular disrupting agent (VDA). … addition, however, preclinical data demonstrates that OXI-4503 is metabolized by oxidative enzymes (e.g., tyrosinase and peroxidases), which are elevated in many solid tumors and tumor infiltrates, to an

  9. Drug

    FavId

    go.drugbank.com/drugs/DB05249
    Investigational

    FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.

  10. Drug

    Budiodarone

    go.drugbank.com/drugs/DB05519
    Investigational

    Budiodarone (ATI-2042) is an antiarrhythmic related to amiodarone that is currently being studied in clinical trials.